Back to News & Events

default image

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Jan 08, 2021

Posted By:

ALD Connect

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Posted In:

Statement for ALD Patients Considering the COVID-19 Vaccine

Quality of life in women with X-ALD